EGFR and infection: In addition, we conducted sub-group analysis based on treatment regimens, and demonstrated that the addition of EGFR-TKIs to chemotherapy had a tendency to increase the risk of infections in comparison with chemotherapy alone (Peto OR 1.24, 95%CI: 0.75-3.05, p = 0.39).